These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 9730425)

  • 21. Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation.
    Dandel M; Jasaityte R; Lehmkuhl H; Knosalla C; Hetzer R
    Transplant Proc; 2009; 41(6):2585-8. PubMed ID: 19715979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney graft outcomes in living-related transplantation have improved with substitution of basiliximab and mycophenolate mofetil for antithymocyte globulin and azathioprine: a single center retrospective cohort study.
    Imamović G; Zerem E; Osmanović E
    Eur J Intern Med; 2010 Dec; 21(6):524-9. PubMed ID: 21111938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.
    Transplantation; 1999 Aug; 68(3):391-6. PubMed ID: 10459543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.
    Halloran P; Mathew T; Tomlanovich S; Groth C; Hooftman L; Barker C
    Transplantation; 1997 Jan; 63(1):39-47. PubMed ID: 9000658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant.
    Wijesinha M; Hirshon JM; Terrin M; Magder L; Brown C; Stafford K; Iacono A
    JAMA Netw Open; 2019 Aug; 2(8):e1910297. PubMed ID: 31461151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of the immunosuppressive protocol after lung transplantation.
    Reichenspurner H; Kur F; Treede H; Meiser BM; Deutsch O; Welz A; Vogelmeier C; Schwaiblmair M; Müller C; Fürst H; Briegel J; Reichart B
    Transplantation; 1999 Jul; 68(1):67-71. PubMed ID: 10428269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients.
    Hamour IM; Lyster HS; Burke MM; Rose ML; Banner NR
    Transplantation; 2007 Mar; 83(5):570-6. PubMed ID: 17353776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.
    Bernabeu-Wittel M; Naranjo M; Cisneros JM; Cañas E; Gentil MA; Algarra G; Pereira P; González-Roncero FJ; de Alarcón A; Pachón J
    Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):173-80. PubMed ID: 11957018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved outcome of pediatric kidney transplantations in the Netherlands -- effect of the introduction of mycophenolate mofetil?
    Cransberg K; Marlies Cornelissen EA; Davin JC; Van Hoeck KJ; Lilien MR; Stijnen T; Nauta J
    Pediatr Transplant; 2005 Feb; 9(1):104-11. PubMed ID: 15667622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of mycophenolate mofetil in heart transplantation.
    Mathieu P; Carrier M; White M; Pellerin M; Perrault L; Pelletier G; Robitaille D; Pelletier LC
    Can J Surg; 2000 Jun; 43(3):202-6. PubMed ID: 10851414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
    J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
    Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
    J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials.
    Ross DJ; Jordan SC; Nathan SD; Kass RM; Koerner SK
    Chest; 1996 Apr; 109(4):870-3. PubMed ID: 8635362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
    von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.
    Ahsan N; Hricik D; Matas A; Rose S; Tomlanovich S; Wilkinson A; Ewell M; McIntosh M; Stablein D; Hodge E
    Transplantation; 1999 Dec; 68(12):1865-74. PubMed ID: 10628766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation.
    Oh JM; Wiland AM; Klassen DK; Weidle PJ; Bartlett ST
    J Clin Pharmacol; 2001 Aug; 41(8):861-9. PubMed ID: 11504274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.